Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigonal versus trigone-sparing Dysport injection for idiopathic detrusor overactivity
ISRCTN12589059Phase 3Completed
- Sponsor
- Tallaght University Hospital
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of botulinum toxin type A in idiopathic detrusor overactivity (IDO) (2 arms), sponsored by Tallaght University Hospital. Primary endpoint: Overactive Bladder Symptom Score Questionnaire total score at 6 weeks. Started Sep 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic detrusor overactivity (IDO)
Beyond the preview
Go deeper on ISRCTN12589059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12589059.